Conexeu Sciences targets Q1 2027 FDA 510(k) submission for wound device

October 6, 2026 8:30 AM

Conexeu Sciences Inc. (Nasdaq: CNXU), a preclinical-stage medical device company based in Reno, Nevada, said it remains on track to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found